patent/BR-PI0922839-A2

http://rdf.ncbi.nlm.nih.gov/pubchem/patent/BR-PI0922839-A2

Outgoing Links

Predicate	Object
assignee	http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8546d028451f0334fbee4155e029e692
classificationCPCInventive	http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-555 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D213-38 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-444 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K51-0497 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D403-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4192 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C275-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K51-041 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K51-0478 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07F13-005 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K51-0474 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P13-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K51-0402 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C311-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D403-12
classificationIPCInventive	http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D213-38 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K51-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07F13-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K51-08
filingDate	2009-12-04-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor	http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7721470bdd4b1822b4f0cf14c26dd800 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_94f8c78c70d893733a7f7afbbd73bbb2 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0b8779c5e457c0cd4dc96d1b09c6719d http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a700256607eb8e4995411f15927ce92a http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_118fb9c8de60738dafdc4260f20e92bf http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5c600351060dedb264301faa5fb69cf7
publicationDate	2019-09-03-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber	BR-PI0922839-A2
titleOfInvention	ca-ix-specific radiopharmaceuticals for cancer treatment and imaging.
abstract	CAXI-Specific Radiopharmaceuticals for Cancer Treatment and Imaging The present invention relates to a compound that recognizes and binds to ca-IX protein of formula I, II, III or IV. The compounds may include a radioactive element for radio imaging or therapeutic applications. thus, pharmaceutical compositions may be prepared with one or more of the compounds of formula i, ii, iii, or iv.
priorityDate	2008-12-05-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type	http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID467968672

Total number of triples: 38.